Document is current
Any future updates will be listed below
-
Authors
Ziaeian, Boback https://orcid.org/0000-0001-9787-3649
Xu, Haolin
Matsouaka, Roland A.
Xian, Ying
Khan, Yosef
Schwamm, Lee S.
Smith, Eric E.
Fonarow, Gregg C.
-
Funding
Funding for this research was provided by:
American Heart Association (17SDG33630113)
National Center for Advancing Translational Sciences (KL2TR001882)
- License Information
-
More Information
Article History
Received: 2 November 2020
Accepted: 22 January 2021
First Online: 4 February 2021
Ethics approval and consent to participate
: A waiver for consent is applied to this study and the Get With The Guideline Registry Program through the Duke University IRB.
: Not applicable.
: Boback Ziaeian: none.Gregg C. Fonarow: Research: NIH; Consulting: Abbott, Amgen, Bayer, Janssen, Medtronic, and Novartis.Lee H Schwamm: Research grants: NINDS, NIA, PCORI; Serves on scientific advisory boards for (1) LifeImage (2) Medtronic clinical trial design for AF related stroke (3) Penumbra MIND study DSMB , (4) Genentech TIMELESS study Steering Committee, and expert advisory panel on late window thrombolysis, (5) Diffusion Pharma DSMB PHAST-TSC NCT03763929. Serves as volunteer chair of the AHA/ASA stroke systems of care advisory committee, and ASA Advisory Committee of the AHA Board of Directors [unpaid].
